Log in

NYSEARCA:ALTiShares Diversified Alternatives Trust Stock Price, Forecast & News

$9.93
-0.49 (-4.70 %)
(As of 07/7/2020 04:00 PM ET)
Add
Compare
Today's Range
$9.63
Now: $9.93
$10.60
50-Day Range
$4.48
MA: $8.12
$10.71
52-Week Range
$1.51
Now: $9.93
$12.74
Volume1.18 million shs
Average Volume2.11 million shs
Market Capitalization$154.18 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Altimmune, Inc., a clinical stage biopharmaceutical company, focused developing treatments for liver disease, immune modulating therapies, and vaccines. The company develops HepTcell, an immunotherapeutic product candidate that has completed Phase I clinical trial for patients chronically infected with the hepatitis B virus; NasoShield, an anthrax vaccine to provide for protection after a single intranasal administration; NasoVAX, a recombinant intranasal vaccine product candidate; and AdCOVID, a single-dose intranasal vaccine to protect against COVID-19 Its preclinical stage products include ALT-801, a novel peptide-based dual GLP-1/Glucagon receptor agonist for the treatment of non-alcoholic steatohepatitis; and ALT-702, an investigational tumor immunostimulant for treating cancer. The company also develops veterinary product candidates. It has a collaboration with the University of Alabama at Birmingham for the development of AdCOVID. Altimmune, Inc. is headquartered in Gaithersburg, Maryland.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 1.5Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 3.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.38 out of 5 stars


Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
Current SymbolNYSEARCA:ALT
CUSIPN/A
Phone+1-415-6702000

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees25
Market Cap$154.18 million
Next Earnings Date8/11/2020 (Estimated)
OptionableOptionable

Receive ALT News and Ratings via Email

Sign-up to receive the latest news and ratings for ALT and its competitors with MarketBeat's FREE daily newsletter.

iShares Diversified Alternatives Trust (NYSEARCA:ALT) Frequently Asked Questions

How has iShares Diversified Alternatives Trust's stock been impacted by COVID-19 (Coronavirus)?

iShares Diversified Alternatives Trust's stock was trading at $3.19 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, ALT shares have increased by 211.3% and is now trading at $9.93. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of iShares Diversified Alternatives Trust?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for iShares Diversified Alternatives Trust in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for iShares Diversified Alternatives Trust.

When is iShares Diversified Alternatives Trust's next earnings date?

iShares Diversified Alternatives Trust is scheduled to release its next quarterly earnings announcement on Tuesday, August 11th 2020. View our earnings forecast for iShares Diversified Alternatives Trust.

How were iShares Diversified Alternatives Trust's earnings last quarter?

iShares Diversified Alternatives Trust (NYSEARCA:ALT) issued its earnings results on Wednesday, May, 13th. The company reported ($0.26) EPS for the quarter, topping analysts' consensus estimates of ($0.32) by $0.06. The company earned $2.21 million during the quarter, compared to analysts' expectations of $0.50 million. View iShares Diversified Alternatives Trust's earnings history.

When did iShares Diversified Alternatives Trust's stock split? How did iShares Diversified Alternatives Trust's stock split work?

iShares Diversified Alternatives Trust shares reverse split on Friday, September 14th 2018. The 1-30 reverse split was announced on Thursday, September 13th 2018. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, September 13th 2018. An investor that had 100 shares of iShares Diversified Alternatives Trust stock prior to the reverse split would have 3 shares after the split.

What price target have analysts set for ALT?

1 Wall Street analysts have issued 12-month price objectives for iShares Diversified Alternatives Trust's stock. Their forecasts range from $8.30 to $8.30. On average, they expect iShares Diversified Alternatives Trust's stock price to reach $8.30 in the next twelve months. This suggests that the stock has a possible downside of 16.4%. View analysts' price targets for iShares Diversified Alternatives Trust.

Has iShares Diversified Alternatives Trust been receiving favorable news coverage?

Media headlines about ALT stock have been trending negative on Wednesday, according to InfoTrie Sentiment Analysis. The research firm scores the sentiment of media coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. iShares Diversified Alternatives Trust earned a media sentiment score of -2.1 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the company's share price in the near future. View the latest news about iShares Diversified Alternatives Trust.

Who are some of iShares Diversified Alternatives Trust's key competitors?

What other stocks do shareholders of iShares Diversified Alternatives Trust own?

Based on aggregate information from My MarketBeat watchlists, some companies that other iShares Diversified Alternatives Trust investors own include AbbVie (ABBV), Amplify Energy (AMPY), Amplify Energy (AMPY), Aravive (ARAV), CAN-FITE BIOPHA/S (CANF), Corbus Pharmaceuticals (CRBP), Carvana (CVNA), Energy Transfer LP Unit (ET), Goodrich Petroleum (GDP) and Goodrich Petroleum (GDP).

Who are iShares Diversified Alternatives Trust's key executives?

iShares Diversified Alternatives Trust's management team includes the following people:
  • Dr. Mitchel B. Sayare, Exec. Chairman (Age 72, Pay $65k)
  • Dr. Vipin K. Garg, Pres, CEO & Director (Age 62, Pay $566.63k)
  • Mr. William Michael Brown, CFO & Principal Accounting Officer (Age 38, Pay $443.16k)
  • Dr. Matthew Scott Harris M.D., MS, FCAP, AGAF, Chief Medical Officer (Age 67, Pay $371.29k)
  • Mr. Bertrand Georges Ph.D., Chief Technology Officer

What is iShares Diversified Alternatives Trust's stock symbol?

iShares Diversified Alternatives Trust trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "ALT."

How do I buy shares of iShares Diversified Alternatives Trust?

Shares of ALT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is iShares Diversified Alternatives Trust's stock price today?

One share of ALT stock can currently be purchased for approximately $9.93.

How big of a company is iShares Diversified Alternatives Trust?

iShares Diversified Alternatives Trust has a market capitalization of $154.18 million. iShares Diversified Alternatives Trust employs 25 workers across the globe.

What is iShares Diversified Alternatives Trust's official website?

The official website for iShares Diversified Alternatives Trust is www.ishares.com.

How can I contact iShares Diversified Alternatives Trust?

iShares Diversified Alternatives Trust's mailing address is c/o BlackRock Asset Mgmt Internatnl Inc. 400 Howard Street, SAN FRANCISCO, CA 94105, United States. The company can be reached via phone at +1-415-6702000.

This page was last updated on 7/8/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.